Healthcare Sector Stocks
The Healthcare sector has a total of 1058 stocks, with a combined market cap of $8.54 trillion, total revenue of $4.59 trillion and a weighted average PE ratio of 42.87.
Market Cap
8.54T
Revenue
4.59T
Profits
199.12B
PE Ratio
42.87
Profit Margin
4.34%
Dividend Yield
0.42%
1059 Stocks
| No. | Symbol | Company Name | Market Cap | % Change | Volume | Revenue |
|---|---|---|---|---|---|---|
| 1 | LLY | Eli Lilly and Company | 987.23B | 0.45% | 3,316,278 | 72.25B |
| 2 | JNJ | Johnson & Johnson | 575.52B | 3.37% | 11,802,002 | 96.36B |
| 3 | ABBV | AbbVie Inc. | 414.77B | 2.07% | 7,366,040 | 62.82B |
| 4 | UNH | UnitedHealth Group Incorporated | 371.66B | 0.63% | 6,675,885 | 449.71B |
| 5 | MRK | Merck & Co., Inc. | 295.39B | 3.57% | 10,469,255 | 65.77B |
| 6 | NVS | Novartis AG | 279.10B | 2.99% | 1,403,616 | 56.58B |
| 7 | AZN | AstraZeneca PLC | 278.15B | 2.60% | 1,503,883 | 60.44B |
| 8 | NVO | Novo Nordisk A/S | 207.52B | 3.36% | 17,674,250 | 50.57B |
| 9 | AMGN | Amgen Inc. | 187.28B | 0.66% | 2,304,951 | 37.22B |
| 10 | TMO | Thermo Fisher Scientific Inc. | 174.42B | 1.15% | 1,824,725 | 45.20B |
| 11 | ABT | Abbott Laboratories | 157.69B | 3.07% | 12,201,914 | 45.13B |
| 12 | GILD | Gilead Sciences, Inc. | 155.26B | 0.14% | 8,462,590 | 29.74B |
| 13 | ISRG | Intuitive Surgical, Inc. | 142.79B | 0.06% | 2,705,176 | 10.58B |
| 14 | PFE | Pfizer Inc. | 140.89B | -1.44% | 82,009,211 | 63.32B |
| 15 | CVS | CVS Health Corporation | 129.60B | 0.27% | 6,435,318 | 405.62B |
| 16 | DHR | Danaher Corporation | 126.67B | 0.44% | 4,149,961 | 24.78B |
| 17 | VRTX | Vertex Pharmaceuticals Incorporated | 118.89B | 0.35% | 1,204,019 | 12.22B |
| 18 | SYK | Stryker Corporation | 118.84B | 1.74% | 2,260,596 | 25.27B |
| 19 | BMY | Bristol-Myers Squibb Company | 113.40B | 1.52% | 13,250,980 | 48.48B |
| 20 | MDT | Medtronic plc | 103.21B | 1.72% | 8,482,605 | 36.36B |
| 21 | GSK | GSK plc | 102.93B | 2.62% | 3,008,451 | 43.29B |
| 22 | SNY | Sanofi | 100.38B | -0.43% | 10,855,608 | 54.60B |
| 23 | MCK | McKesson Corporation | 89.44B | 2.56% | 1,363,683 | 403.43B |
| 24 | HCA | HCA Healthcare, Inc. | 85.83B | 2.63% | 1,107,504 | 76.39B |
| 25 | ELV | Elevance Health, Inc. | 85.80B | 0.07% | 1,257,044 | 200.42B |
| 26 | CI | The Cigna Group | 74.88B | 0.35% | 1,402,170 | 277.89B |
| 27 | BSX | Boston Scientific Corporation | 67.78B | 2.86% | 18,696,072 | 20.61B |
| 28 | REGN | Regeneron Pharmaceuticals, Inc. | 62.88B | 0.90% | 1,279,872 | 14.92B |
| 29 | ARGX | argenx SE | 57.55B | -5.57% | 719,519 | 4.74B |
| 30 | COR | Cencora, Inc. | 54.69B | 3.62% | 1,725,937 | 328.68B |
| 31 | CAH | Cardinal Health, Inc. | 53.61B | 2.77% | 2,110,477 | 250.74B |
| 32 | EW | Edwards Lifesciences Corporation | 50.07B | 1.25% | 4,228,238 | 6.30B |
| 33 | TAK | Takeda Pharmaceutical Company Limited | 49.01B | 2.39% | 3,126,624 | 28.34B |
| 34 | MDLN | Medline Inc. | 46.37B | 1.70% | 5,581,132 | 29.14B |
| 35 | HUM | Humana Inc. | 43.12B | -0.44% | 1,568,593 | 137.20B |
| 36 | IDXX | IDEXX Laboratories, Inc. | 42.70B | -0.81% | 652,229 | 4.45B |
| 37 | BDX | Becton, Dickinson and Company | 39.66B | 2.28% | 2,908,135 | 22.23B |
| 38 | HLN | Haleon plc | 38.82B | 2.05% | 10,874,194 | 14.85B |
| 39 | TEVA | Teva Pharmaceutical Industries Limited | 38.67B | 3.14% | 5,567,373 | 17.35B |
| 40 | ALNY | Alnylam Pharmaceuticals, Inc. | 38.48B | 0.62% | 1,087,832 | 4.29B |
| 41 | RVMD | Revolution Medicines, Inc. | 36.04B | 2.23% | 3,124,242 | - |
| 42 | A | Agilent Technologies, Inc. | 35.78B | 0.14% | 2,117,826 | 7.23B |
| 43 | WAT | Waters Corporation | 35.07B | -0.29% | 843,317 | 3.77B |
| 44 | NTRA | Natera, Inc. | 33.62B | 2.60% | 2,063,404 | 2.50B |
| 45 | ZTS | Zoetis Inc. | 32.21B | 1.25% | 5,859,339 | 9.53B |
| 46 | ALC | Alcon Inc. | 32.10B | 1.44% | 2,291,954 | 10.63B |
| 47 | RPRX | Royalty Pharma plc | 31.87B | 3.32% | 4,896,197 | 2.44B |
| 48 | CNC | Centene Corporation | 31.18B | -0.85% | 4,990,883 | 178.33B |
| 49 | ONC | BeOne Medicines AG | 30.70B | 1.59% | 331,646 | 5.70B |
| 50 | BIIB | Biogen Inc. | 29.11B | -1.26% | 1,053,493 | 9.94B |
| 51 | GEHC | GE HealthCare Technologies Inc. | 28.99B | 5.08% | 7,762,738 | 20.98B |
| 52 | IQV | IQVIA Holdings Inc. | 28.59B | 2.07% | 1,622,229 | 16.63B |
| 53 | RMD | ResMed Inc. | 27.62B | 1.49% | 1,235,525 | 5.54B |
| 54 | DXCM | DexCom, Inc. | 26.59B | -0.22% | 6,347,655 | 4.82B |
| 55 | VEEV | Veeva Systems Inc. | 25.94B | 4.28% | 3,066,626 | 3.32B |
| 56 | PHG | Koninklijke Philips N.V. | 25.37B | -1.37% | 748,187 | 20.34B |
| 57 | ILMN | Illumina, Inc. | 24.95B | 2.20% | 2,062,649 | 4.39B |
| 58 | MRNA | Moderna, Inc. | 24.20B | 2.78% | 6,814,161 | 2.23B |
| 59 | WST | West Pharmaceutical Services, Inc. | 23.77B | 2.03% | 784,658 | 3.22B |
| 60 | MTD | Mettler-Toledo International Inc. | 23.37B | -0.64% | 306,066 | 4.09B |
| 61 | ROIV | Roivant Sciences Ltd. | 23.17B | 3.07% | 7,365,170 | 8.26M |
| 62 | UTHR | United Therapeutics Corporation | 23.11B | 1.12% | 1,081,315 | 3.17B |
| 63 | BNTX | BioNTech SE | 22.92B | 0.48% | 552,902 | 3.23B |
| 64 | INSM | Insmed Incorporated | 22.14B | 3.59% | 4,199,730 | 819.56M |
| 65 | DGX | Quest Diagnostics Incorporated | 21.83B | 1.86% | 987,971 | 11.28B |
| 66 | LH | Labcorp Holdings Inc. | 21.20B | 1.64% | 414,726 | 14.14B |
| 67 | INCY | Incyte Corporation | 20.86B | 0.71% | 1,670,985 | 5.36B |
| 68 | STE | STERIS plc | 19.80B | 1.40% | 863,161 | 5.94B |
| 69 | VTRS | Viatris Inc. | 18.34B | 2.41% | 8,811,119 | 14.56B |
| 70 | GH | Guardant Health, Inc. | 17.35B | 1.55% | 1,931,997 | 1.08B |
| 71 | ZBH | Zimmer Biomet Holdings, Inc. | 16.94B | 0.55% | 1,789,666 | 8.41B |
| 72 | NBIX | Neurocrine Biosciences, Inc. | 16.23B | -0.11% | 1,076,140 | 3.10B |
| 73 | GMAB | Genmab A/S | 15.97B | 1.29% | 1,262,306 | 3.90B |
| 74 | THC | Tenet Healthcare Corporation | 15.58B | 1.19% | 831,544 | 21.46B |
| 75 | ASND | Ascendis Pharma A/S | 14.82B | 4.64% | 836,579 | 998.25M |
| 76 | JAZZ | Jazz Pharmaceuticals plc | 14.45B | 1.92% | 862,820 | 4.44B |
| 77 | BTSG | BrightSpring Health Services, Inc. | 13.92B | -0.54% | 2,406,629 | 13.65B |
| 78 | DVA | DaVita Inc. | 13.54B | 0.60% | 858,135 | 13.84B |
| 79 | MEDP | Medpace Holdings, Inc. | 13.52B | 3.91% | 312,103 | 2.68B |
| 80 | BBIO | BridgeBio Pharma, Inc. | 13.44B | -0.42% | 2,455,145 | 579.96M |
| 81 | EXEL | Exelixis, Inc. | 12.90B | -0.02% | 2,574,378 | 2.38B |
| 82 | COO | The Cooper Companies, Inc. | 12.90B | 1.12% | 2,768,169 | 4.23B |
| 83 | SOLV | Solventum Corporation | 12.81B | 0.58% | 1,536,833 | 8.26B |
| 84 | FMS | Fresenius Medical Care AG | 12.70B | 1.33% | 490,978 | 22.32B |
| 85 | IONS | Ionis Pharmaceuticals, Inc. | 12.56B | 0.13% | 1,405,416 | 1.06B |
| 86 | SNN | Smith & Nephew plc | 12.52B | 0.75% | 986,480 | 6.16B |
| 87 | PEN | Penumbra, Inc. | 12.49B | 0.45% | 307,400 | 1.45B |
| 88 | AXSM | Axsome Therapeutics, Inc. | 12.45B | -2.37% | 1,312,955 | 708.24M |
| 89 | ALGN | Align Technology, Inc. | 12.07B | -3.03% | 1,112,523 | 4.10B |
| 90 | MDGL | Madrigal Pharmaceuticals, Inc. | 11.84B | 0.11% | 266,384 | 1.13B |
| 91 | ELAN | Elanco Animal Health Incorporated | 11.58B | -3.01% | 4,643,757 | 4.89B |
| 92 | RDY | Dr. Reddy's Laboratories Limited | 11.44B | 2.88% | 4,150,860 | 3.58B |
| 93 | ARWR | Arrowhead Pharmaceuticals, Inc. | 11.25B | -2.56% | 1,393,552 | 622.01M |
| 94 | RVTY | Revvity, Inc. | 11.14B | 0.87% | 1,116,258 | 2.90B |
| 95 | SMMT | Summit Therapeutics Inc. | 11.06B | -0.21% | 5,963,357 | - |
| 96 | ICLR | ICON Public Limited Company | 10.92B | 1.38% | 696,206 | 8.27B |
| 97 | BMRN | BioMarin Pharmaceutical Inc. | 10.92B | 1.07% | 2,027,087 | 3.24B |
| 98 | GMED | Globus Medical, Inc. | 10.86B | 1.07% | 1,673,444 | 3.10B |
| 99 | CYTK | Cytokinetics, Incorporated | 10.86B | 1.06% | 2,077,619 | 105.82M |
| 100 | BAX | Baxter International Inc. | 10.38B | 2.24% | 5,072,627 | 11.32B |
| 101 | MOH | Molina Healthcare, Inc. | 10.24B | -0.44% | 850,320 | 43.10B |
| 102 | KRYS | Krystal Biotech, Inc. | 10.03B | -0.94% | 272,795 | 417.30M |
| 103 | PODD | Insulet Corporation | 9.97B | 3.55% | 1,854,939 | 2.90B |
| 104 | APGE | Apogee Therapeutics, Inc. | 9.96B | 0.25% | 11,320,483 | - |
| 105 | EHC | Encompass Health Corporation | 9.91B | 1.24% | 1,369,180 | 6.07B |
| 106 | NUVL | Nuvalent, Inc. | 9.75B | 0.02% | 1,335,904 | - |
| 107 | ENSG | The Ensign Group, Inc. | 9.21B | 1.35% | 924,380 | 5.27B |
| 108 | HSIC | Henry Schein, Inc. | 9.12B | 1.82% | 1,368,035 | 13.38B |
| 109 | OSCR | Oscar Health, Inc. | 9.01B | 4.87% | 7,748,189 | 13.30B |
| 110 | CRL | Charles River Laboratories International, Inc. | 8.99B | 2.78% | 632,149 | 4.03B |
| 111 | UHS | Universal Health Services, Inc. | 8.83B | 2.25% | 823,354 | 17.76B |
| 112 | TECH | Bio-Techne Corporation | 8.81B | 1.17% | 2,314,080 | 1.21B |
| 113 | TEM | Tempus AI, Inc. | 8.73B | 1.59% | 5,326,346 | 1.36B |
| 114 | CORT | Corcept Therapeutics Incorporated | 8.57B | 0.18% | 947,294 | 769.10M |
| 115 | PRAX | Praxis Precision Medicines, Inc. | 8.51B | 0.65% | 519,281 | 7.46M |
| 116 | SYRE | Spyre Therapeutics, Inc. | 8.43B | -3.26% | 2,640,323 | - |
| 117 | BRKR | Bruker Corporation | 8.39B | -2.51% | 2,144,131 | 3.46B |
| 118 | HALO | Halozyme Therapeutics, Inc. | 8.26B | 0.91% | 2,716,069 | 1.51B |
| 119 | KYMR | Kymera Therapeutics, Inc. | 8.08B | -1.21% | 1,368,159 | 51.48M |
| 120 | ALKS | Alkermes plc | 8.01B | 4.45% | 2,451,925 | 1.56B |
| 121 | GKOS | Glaukos Corporation | 7.90B | 2.64% | 546,299 | 551.35M |
| 122 | ABVX | ABIVAX Société Anonyme | 7.77B | -3.18% | 1,561,914 | 5.67M |
| 123 | IMVT | Immunovant, Inc. | 7.72B | -1.26% | 921,873 | - |
| 124 | ATR | AptarGroup, Inc. | 7.70B | 0.51% | 514,116 | 3.87B |
| 125 | QGEN | Qiagen N.V. | 7.69B | 2.54% | 3,526,502 | 2.10B |
| 126 | IBRX | ImmunityBio, Inc. | 7.67B | 1.39% | 11,316,361 | 140.98M |
| 127 | PTGX | Protagonist Therapeutics, Inc. | 7.65B | 3.42% | 700,455 | 74.06M |
| 128 | TGTX | TG Therapeutics, Inc. | 7.64B | -0.85% | 3,140,095 | 700.35M |
| 129 | HIMS | Hims & Hers Health, Inc. | 7.63B | -1.73% | 12,550,440 | 2.37B |
| 130 | PCVX | Vaxcyte, Inc. | 7.50B | -0.29% | 1,211,033 | - |
| 131 | RYTM | Rhythm Pharmaceuticals, Inc. | 7.28B | 4.73% | 1,289,030 | 217.17M |
| 132 | BIO | Bio-Rad Laboratories, Inc. | 7.23B | -3.84% | 645,327 | 2.59B |
| 133 | RGEN | Repligen Corporation | 7.13B | -0.16% | 856,499 | 763.34M |
| 134 | HQY | HealthEquity, Inc. | 7.10B | 0.37% | 983,933 | 1.34B |
| 135 | LNTH | Lantheus Holdings, Inc. | 6.90B | -0.16% | 757,582 | 1.55B |
| 136 | PTCT | PTC Therapeutics, Inc. | 6.81B | 1.45% | 2,307,237 | 827.11M |
| 137 | MIRM | Mirum Pharmaceuticals, Inc. | 6.77B | 3.06% | 1,129,074 | 569.61M |
| 138 | LQDA | Liquidia Corporation | 6.58B | -1.92% | 1,706,017 | 288.07M |
| 139 | AVTR | Avantor, Inc. | 6.44B | 0.86% | 11,462,907 | 6.55B |
| 140 | CNTA | Centessa Pharmaceuticals plc | 6.27B | 0.80% | 11,330,437 | 15.00M |
| 141 | COGT | Cogent Biosciences, Inc. | 6.21B | 1.31% | 4,050,450 | - |
| 142 | GRFS | Grifols, S.A. | 6.17B | -1.37% | 656,349 | 8.58B |
| 143 | SRRK | Scholar Rock Holding Corporation | 6.14B | 4.23% | 2,233,608 | - |
| 144 | PACS | PACS Group, Inc. | 5.91B | -1.06% | 817,373 | 5.43B |
| 145 | CHE | Chemed Corporation | 5.87B | 1.84% | 253,212 | 2.54B |
| 146 | CGON | CG Oncology, Inc. | 5.80B | -0.78% | 846,606 | 5.07M |
| 147 | BLTE | Belite Bio, Inc | 5.71B | -1.35% | 214,856 | - |
| 148 | LGND | Ligand Pharmaceuticals Incorporated | 5.60B | 6.59% | 2,298,219 | 274.48M |
| 149 | TFX | Teleflex Incorporated | 5.50B | 2.13% | 407,232 | 2.13B |
| 150 | RGC | Regencell Bioscience Holdings Limited | 5.49B | 5.42% | 261,678 | - |
| 151 | HNGE | Hinge Health, Inc. | 5.45B | 2.22% | 1,317,635 | 646.34M |
| 152 | LEGN | Legend Biotech Corporation | 5.44B | -0.14% | 2,087,553 | 1.14B |
| 153 | BLCO | Bausch + Lomb Corporation | 5.43B | 2.08% | 418,152 | 5.21B |
| 154 | AMRX | Amneal Pharmaceuticals, Inc. | 5.31B | 3.41% | 1,826,205 | 3.05B |
| 155 | TWST | Twist Bioscience Corporation | 5.29B | -0.20% | 1,768,636 | 409.48M |
| 156 | XENE | Xenon Pharmaceuticals Inc. | 5.28B | -0.33% | 1,498,297 | 7.50M |
| 157 | CRSP | CRISPR Therapeutics AG | 5.21B | -0.68% | 1,534,125 | 4.10M |
| 158 | TVTX | Travere Therapeutics, Inc. | 5.20B | 1.52% | 1,581,782 | 536.20M |
| 159 | ORKA | Oruka Therapeutics, Inc. | 5.03B | -2.32% | 1,328,243 | - |
| 160 | CAI | Caris Life Sciences, Inc. | 4.98B | 1.68% | 2,842,846 | 907.29M |
| 161 | INDV | Indivior Pharmaceuticals, Inc. | 4.87B | 21.16% | 1,562,727 | 1.29B |
| 162 | BLLN | BillionToOne, Inc. | 4.80B | 3.53% | 729,314 | 354.54M |
| 163 | DNTH | Dianthus Therapeutics, Inc. | 4.78B | 0.18% | 969,318 | 1.34M |
| 164 | ERAS | Erasca, Inc. | 4.69B | -0.07% | 4,294,901 | - |
| 165 | STVN | Stevanato Group S.p.A. | 4.61B | -0.41% | 295,687 | 1.39B |
| 166 | KNSA | Kiniksa Pharmaceuticals International, plc | 4.58B | 4.13% | 771,813 | 754.05M |
| 167 | SHC | Sotera Health Company | 4.52B | 0.64% | 2,102,541 | 1.19B |
| 168 | ALHC | Alignment Healthcare, Inc. | 4.48B | 1.74% | 2,641,243 | 4.26B |
| 169 | RDNT | RadNet, Inc. | 4.42B | 0.79% | 640,840 | 2.14B |
| 170 | CELC | Celcuity Inc. | 4.40B | 0.31% | 659,113 | - |
| 171 | MANE | Veradermics, Incorporated | 4.33B | 0.79% | 616,509 | - |
| 172 | LIVN | LivaNova PLC | 4.32B | -0.04% | 576,237 | 1.43B |
| 173 | VCYT | Veracyte, Inc. | 4.29B | 1.13% | 844,898 | 541.74M |
| 174 | EWTX | Edgewise Therapeutics, Inc. | 4.18B | 6.38% | 1,034,948 | - |
| 175 | NVST | Envista Holdings Corporation | 4.11B | -0.98% | 1,932,890 | 2.81B |
| 176 | TNGX | Tango Therapeutics, Inc. | 4.11B | -0.39% | 5,387,185 | 56.99M |
| 177 | TXG | 10x Genomics, Inc. | 4.05B | -3.25% | 3,294,492 | 638.78M |
| 178 | VKTX | Viking Therapeutics, Inc. | 4.04B | 7.54% | 6,218,273 | - |
| 179 | MMSI | Merit Medical Systems, Inc. | 4.01B | 1.16% | 825,492 | 1.54B |
| 180 | DFTX | Definium Therapeutics, Inc. | 3.95B | -1.34% | 5,640,932 | - |
| 181 | DNLI | Denali Therapeutics Inc. | 3.93B | 2.99% | 1,658,566 | - |
| 182 | ACAD | ACADIA Pharmaceuticals Inc. | 3.87B | 2.31% | 1,476,897 | 1.10B |
| 183 | MMED | MiniMed Group, Inc. | 3.86B | -3.38% | 537,618 | 3.10B |
| 184 | CPRX | Catalyst Pharmaceuticals, Inc. | 3.84B | 0.06% | 948,604 | 596.96M |
| 185 | RLAY | Relay Therapeutics, Inc. | 3.80B | 0.93% | 5,390,191 | 10.68M |
| 186 | CRNX | Crinetics Pharmaceuticals, Inc. | 3.79B | 1.50% | 935,104 | 18.07M |
| 187 | DOCS | Doximity, Inc. | 3.75B | 2.04% | 2,878,655 | 644.86M |
| 188 | NAMS | NewAmsterdam Pharma Company N.V. | 3.67B | 1.88% | 999,832 | 22.57M |
| 189 | CON | Concentra Group Holdings Parent, Inc. | 3.67B | 0.60% | 493,465 | 2.23B |
| 190 | LFST | LifeStance Health Group, Inc. | 3.66B | 2.50% | 2,933,507 | 1.49B |
| 191 | IRTC | iRhythm Holdings, Inc. | 3.62B | 5.19% | 837,803 | 787.85M |
| 192 | RCUS | Arcus Biosciences, Inc. | 3.54B | 3.49% | 2,341,906 | 236.00M |
| 193 | OGN | Organon & Co. | 3.53B | 0.37% | 1,533,729 | 6.16B |
| 194 | WAY | Waystar Holding Corp. | 3.53B | 6.35% | 3,583,499 | 1.16B |
| 195 | PBLS | Parabilis Medicines, Inc. | 3.50B | -0.11% | 628,057 | - |
| 196 | OPCH | Option Care Health, Inc. | 3.45B | 3.15% | 2,196,927 | 5.67B |
| 197 | TLX | Telix Pharmaceuticals Limited | 3.42B | 2.10% | 280,165 | 803.79M |
| 198 | ICUI | ICU Medical, Inc. | 3.39B | -0.46% | 232,320 | 2.16B |
| 199 | DYN | Dyne Therapeutics, Inc. | 3.35B | -2.92% | 2,075,797 | - |
| 200 | HAE | Haemonetics Corporation | 3.31B | 0.34% | 625,055 | 1.33B |
| 201 | BEAM | Beam Therapeutics Inc. | 3.30B | -6.56% | 3,604,537 | 164.01M |
| 202 | BKD | Brookdale Senior Living Inc. | 3.30B | -1.07% | 3,235,985 | 3.00B |
| 203 | ARQT | Arcutis Biotherapeutics, Inc. | 3.29B | -1.46% | 1,664,016 | 415.62M |
| 204 | GPCR | Structure Therapeutics Inc. | 3.24B | 0.22% | 1,345,013 | - |
| 205 | WRBY | Warby Parker Inc. | 3.15B | -5.00% | 3,145,510 | 890.57M |
| 206 | ALMS | Alumis Inc. | 3.12B | -0.37% | 1,185,461 | 8.40M |
| 207 | NHC | National HealthCare Corporation | 3.12B | -0.92% | 140,028 | 1.53B |
| 208 | QURE | uniQure N.V. | 3.09B | 10.48% | 3,439,211 | 18.09M |
| 209 | IDYA | IDEAYA Biosciences, Inc. | 3.07B | 1.99% | 1,743,726 | 225.27M |
| 210 | ITGR | Integer Holdings Corporation | 3.04B | -0.62% | 522,843 | 1.86B |
| 211 | PRVA | Privia Health Group, Inc. | 2.99B | 1.06% | 880,679 | 2.25B |
| 212 | HTFL | HeartFlow, Inc. | 2.97B | 1.89% | 1,428,181 | 191.42M |
| 213 | ELVN | Enliven Therapeutics, Inc. | 2.96B | 5.74% | 1,981,934 | - |
| 214 | TARS | Tarsus Pharmaceuticals, Inc. | 2.85B | 4.11% | 1,289,790 | 535.08M |
| 215 | RARE | Ultragenyx Pharmaceutical Inc. | 2.82B | -0.93% | 2,043,024 | 670.00M |
| 216 | KLRA | Kailera Therapeutics, Inc. | 2.77B | -6.60% | 531,383 | - |
| 217 | ADPT | Adaptive Biotechnologies Corporation | 2.76B | -0.81% | 2,272,807 | 295.41M |
| 218 | VERA | Vera Therapeutics, Inc. | 2.74B | -0.60% | 1,933,953 | - |
| 219 | IRON | Disc Medicine, Inc. | 2.69B | -0.49% | 537,249 | - |
| 220 | CLOV | Clover Health Investments, Corp. | 2.67B | -1.56% | 8,481,356 | 2.21B |
| 221 | GRAL | GRAIL, Inc. | 2.62B | -1.59% | 421,137 | 156.12M |
| 222 | CLDX | Celldex Therapeutics, Inc. | 2.59B | -1.29% | 669,865 | 865.00K |
| 223 | SUPN | Supernus Pharmaceuticals, Inc. | 2.58B | - | 544,635 | 776.83M |
| 224 | ESTA | Establishment Labs Holdings Inc. | 2.56B | 1.10% | 345,479 | 229.58M |
| 225 | TMDX | TransMedics Group, Inc. | 2.55B | -2.22% | 822,777 | 635.89M |
| 226 | GRDN | Guardian Pharmacy Services, Inc. | 2.48B | -6.45% | 477,465 | 1.46B |
| 227 | TRVI | Trevi Therapeutics, Inc. | 2.47B | -1.86% | 3,279,526 | - |
| 228 | AXGN | Axogen, Inc. | 2.38B | -0.58% | 1,100,193 | 238.11M |
| 229 | BCRX | BioCryst Pharmaceuticals, Inc. | 2.37B | 1.86% | 5,144,625 | 885.72M |
| 230 | PHVS | Pharvaris N.V. | 2.32B | 0.58% | 326,668 | - |
| 231 | KOD | Kodiak Sciences Inc. | 2.31B | 1.15% | 586,399 | - |
| 232 | AUPH | Aurinia Pharmaceuticals Inc. | 2.30B | 2.00% | 2,187,892 | 298.30M |
| 233 | ACHC | Acadia Healthcare Company, Inc. | 2.26B | -2.66% | 2,981,664 | 3.37B |
| 234 | NKTR | Nektar Therapeutics | 2.25B | 1.51% | 796,981 | 55.63M |
| 235 | BHVN | Biohaven Ltd. | 2.23B | -4.65% | 2,488,311 | - |
| 236 | OCUL | Ocular Therapeutix, Inc. | 2.21B | 1.45% | 2,756,826 | 52.04M |
| 237 | MBX | MBX Biosciences, Inc. | 2.21B | 5.65% | 669,311 | - |
| 238 | IMNM | Immunome, Inc. | 2.19B | 0.78% | 2,175,119 | 4.02M |
| 239 | PBH | Prestige Consumer Healthcare Inc. | 2.18B | 1.30% | 724,385 | 1.09B |
| 240 | NTLA | Intellia Therapeutics, Inc. | 2.13B | -3.17% | 4,883,995 | 66.09M |
| 241 | AGIO | Agios Pharmaceuticals, Inc. | 2.12B | 1.40% | 744,424 | 66.05M |
| 242 | MLYS | Mineralys Therapeutics, Inc. | 2.11B | 0.95% | 1,380,926 | - |
| 243 | NUVB | Nuvation Bio Inc. | 2.10B | 4.86% | 4,604,807 | 143.05M |
| 244 | LMAT | LeMaitre Vascular, Inc. | 2.10B | 3.77% | 441,762 | 256.28M |
| 245 | PGNY | Progyny, Inc. | 2.09B | 1.33% | 1,276,826 | 1.29B |
| 246 | ZLAB | Zai Lab Limited | 2.08B | 0.05% | 1,669,941 | 453.28M |
| 247 | VCEL | Vericel Corporation | 2.06B | -0.20% | 430,145 | 292.09M |
| 248 | SEM | Select Medical Holdings Corporation | 2.05B | 0.06% | 731,678 | 5.52B |
| 249 | XRAY | DENTSPLY SIRONA Inc. | 2.04B | 0.49% | 4,456,946 | 3.68B |
| 250 | ASTH | Astrana Health, Inc. | 2.04B | 4.07% | 737,070 | 3.53B |
| 251 | ADMA | ADMA Biologics, Inc. | 2.01B | 1.40% | 2,993,599 | 509.86M |
| 252 | BFLY | Butterfly Network, Inc. | 2.01B | 5.50% | 12,760,314 | 102.92M |
| 253 | KARD | Kardigan, Inc. | 1.99B | -2.33% | 548,482 | - |
| 254 | IOVA | Iovance Biotherapeutics, Inc. | 1.98B | 9.36% | 17,975,950 | 285.61M |
| 255 | GENB | Generate Biomedicines, Inc. | 1.98B | -2.89% | 832,100 | 30.30M |
| 256 | HRMY | Harmony Biosciences Holdings, Inc. | 1.98B | 2.18% | 467,849 | 899.11M |
| 257 | TSHA | Taysha Gene Therapies, Inc. | 1.97B | 5.05% | 1,987,597 | 7.47M |
| 258 | NRIX | Nurix Therapeutics, Inc. | 1.95B | 1.13% | 1,947,315 | 71.78M |
| 259 | MESO | Mesoblast Limited | 1.95B | -0.77% | 138,898 | 65.38M |
| 260 | STOK | Stoke Therapeutics, Inc. | 1.94B | 0.45% | 1,182,653 | 32.08M |
| 261 | NEOG | Neogen Corporation | 1.92B | -1.01% | 2,757,112 | 870.56M |
| 262 | MD | Pediatrix Medical Group, Inc. | 1.91B | 1.45% | 580,836 | 1.93B |
| 263 | PGEN | Precigen, Inc. | 1.91B | -0.37% | 5,246,933 | 31.60M |
| 264 | VRDN | Viridian Therapeutics, Inc. | 1.91B | -1.99% | 1,666,240 | 70.92M |
| 265 | LKFT | Lakefront Biotherapeutics NV | 1.90B | 0.38% | 149,689 | 1.20B |
| 266 | SGRY | Surgery Partners, Inc. | 1.88B | -0.14% | 696,148 | 3.34B |
| 267 | AGL | agilon health, inc. | 1.86B | -1.22% | 378,865 | 5.82B |
| 268 | RAPP | Rapport Therapeutics, Inc. | 1.86B | 1.81% | 206,199 | 20.00M |
| 269 | SRPT | Sarepta Therapeutics, Inc. | 1.82B | -2.21% | 2,371,700 | 2.18B |
| 270 | AMLX | Amylyx Pharmaceuticals, Inc. | 1.82B | 0.55% | 1,852,930 | -665.00K |
| 271 | UFPT | UFP Technologies, Inc. | 1.81B | 0.51% | 170,759 | 608.85M |
| 272 | SION | Sionna Therapeutics, Inc. | 1.80B | 2.68% | 540,441 | - |
| 273 | NBTX | Nanobiotix S.A. | 1.80B | 3.89% | 124,547 | 38.27M |
| 274 | PLSE | Pulse Biosciences, Inc. | 1.80B | 0.93% | 180,052 | 751.00K |
| 275 | BHC | Bausch Health Companies Inc. | 1.79B | 2.78% | 1,222,927 | 10.53B |
| 276 | HCM | HUTCHMED (China) Limited | 1.79B | 1.70% | 22,772 | 548.51M |
| 277 | TYRA | Tyra Biosciences, Inc. | 1.79B | -0.27% | 1,031,993 | - |
| 278 | AVAH | Aveanna Healthcare Holdings Inc. | 1.79B | 3.54% | 2,944,512 | 2.52B |
| 279 | ANIP | ANI Pharmaceuticals, Inc. | 1.76B | 2.93% | 378,059 | 923.71M |
| 280 | ADUS | Addus HomeCare Corporation | 1.76B | 1.12% | 222,910 | 1.45B |
| 281 | GLUE | Monte Rosa Therapeutics, Inc. | 1.75B | 10.93% | 1,753,293 | 42.95M |
| 282 | OMCL | Omnicell, Inc. | 1.75B | -0.70% | 380,637 | 1.23B |
| 283 | ZYME | Zymeworks Inc. | 1.74B | 2.67% | 623,542 | 81.26M |
| 284 | INVA | Innoviva, Inc. | 1.74B | 3.88% | 635,290 | 420.69M |
| 285 | SNDX | Syndax Pharmaceuticals, Inc. | 1.74B | 1.50% | 1,015,688 | 217.17M |
| 286 | ANAB | AnaptysBio, Inc. | 1.73B | -0.93% | 405,993 | 232.39M |
| 287 | WGS | GeneDx Holdings Corp. | 1.72B | 4.80% | 1,010,964 | 442.68M |
| 288 | ABCL | AbCellera Biologics Inc. | 1.72B | -1.92% | 5,520,014 | 79.21M |
| 289 | CAPR | Capricor Therapeutics, Inc. | 1.71B | 0.89% | 794,705 | 11.13M |
| 290 | VIR | Vir Biotechnology, Inc. | 1.71B | 6.17% | 2,534,154 | 65.50M |
| 291 | URGN | UroGen Pharma Ltd. | 1.71B | 0.46% | 465,339 | 140.49M |
| 292 | SNDA | Sonida Senior Living, Inc. | 1.71B | 0.22% | 540,673 | 367.34M |
| 293 | CMPS | COMPASS Pathways plc | 1.71B | 0.16% | 2,363,467 | - |
| 294 | PVLA | Palvella Therapeutics, Inc. | 1.70B | -0.13% | 198,801 | - |
| 295 | SLS | SELLAS Life Sciences Group, Inc. | 1.69B | 6.33% | 7,245,051 | - |
| 296 | RXRX | Recursion Pharmaceuticals, Inc. | 1.68B | -0.63% | 11,169,434 | 66.41M |
| 297 | SEPN | Septerna, Inc. | 1.65B | 4.94% | 312,457 | 72.26M |
| 298 | BCAX | Bicara Therapeutics Inc. | 1.64B | 1.83% | 717,330 | - |
| 299 | TRLV | Trulieve Cannabis Corp. | 1.64B | -6.47% | 2,525,904 | 1.17B |
| 300 | NVCR | NovoCure Limited | 1.64B | 3.82% | 1,752,294 | 674.41M |
| 301 | GHRS | GH Research PLC | 1.62B | 6.88% | 308,091 | - |
| 302 | HROW | Harrow, Inc. | 1.59B | 0.87% | 1,299,397 | 268.68M |
| 303 | ALMR | Alamar Biosciences, Inc. | 1.59B | 0.70% | 256,041 | 87.16M |
| 304 | AVBP | ArriVent BioPharma, Inc. | 1.57B | 3.18% | 850,183 | - |
| 305 | MLTX | MoonLake Immunotherapeutics | 1.56B | -4.24% | 1,737,498 | - |
| 306 | FTRE | Fortrea Holdings Inc. | 1.56B | 5.78% | 1,167,921 | 2.71B |
| 307 | HCSG | Healthcare Services Group, Inc. | 1.55B | 0.49% | 598,418 | 1.85B |
| 308 | ARDX | Ardelyx, Inc. | 1.53B | -2.98% | 3,087,211 | 427.68M |
| 309 | ATAI | AtaiBeckley Inc. | 1.51B | 1.23% | 3,968,181 | 3.49M |
| 310 | NEO | NeoGenomics, Inc. | 1.49B | 2.41% | 3,521,948 | 745.97M |
| 311 | AKTS | Aktis Oncology, Inc. | 1.49B | 8.96% | 408,080 | 8.28M |
| 312 | IMCR | Immunocore Holdings plc | 1.49B | -0.51% | 623,946 | 412.81M |
| 313 | NVAX | Novavax, Inc. | 1.48B | - | 4,235,736 | 596.34M |
| 314 | AAPG | Ascentage Pharma Group International | 1.48B | -0.70% | 18,056 | 82.08M |
| 315 | SVRA | Savara Inc. | 1.47B | 1.58% | 1,856,693 | - |
| 316 | MAZE | Maze Therapeutics, Inc. | 1.46B | 3.29% | 649,115 | 20.00M |
| 317 | ATRC | AtriCure, Inc. | 1.44B | - | 727,353 | 552.16M |
| 318 | DMRA | Damora Therapeutics, Inc. | 1.41B | -3.98% | 325,734 | - |
| 319 | STAA | STAAR Surgical Company | 1.41B | -1.63% | 584,129 | 290.38M |
| 320 | TDOC | Teladoc Health, Inc. | 1.39B | 1.45% | 3,673,949 | 2.51B |
| 321 | MRVI | Maravai LifeSciences Holdings, Inc. | 1.39B | 2.29% | 1,138,516 | 204.73M |
| 322 | IART | Integra LifeSciences Holdings Corporation | 1.38B | 0.51% | 860,760 | 1.64B |
| 323 | INBX | Inhibrx Biosciences, Inc. | 1.36B | -0.42% | 342,790 | 1.30M |
| 324 | IMTX | Immatics N.V. | 1.35B | 1.33% | 347,257 | 43.00M |
| 325 | AVLN | Avalyn Pharma Inc. | 1.35B | -2.06% | 350,574 | - |
| 326 | ARDT | Ardent Health, Inc. | 1.32B | 1.66% | 334,463 | 6.43B |
| 327 | PRGO | Perrigo Company plc | 1.31B | -1.15% | 3,340,319 | 4.18B |
| 328 | ATEC | Alphatec Holdings, Inc. | 1.31B | -0.58% | 2,080,601 | 787.08M |
| 329 | JBIO | Jade Biosciences, Inc. | 1.30B | 12.96% | 1,410,120 | - |
| 330 | MPLT | MapLight Therapeutics, Inc. | 1.30B | -3.86% | 360,124 | - |
| 331 | CDNA | CareDx, Inc. | 1.30B | 0.28% | 691,377 | 412.82M |
| 332 | AHCO | AdaptHealth Corp. | 1.29B | 0.41% | 2,019,887 | 3.29B |
| 333 | COAG | Hemab Therapeutics Holdings, Inc. | 1.29B | -8.16% | 347,900 | - |
| 334 | ZBIO | Zenas BioPharma, Inc. | 1.28B | -2.86% | 513,377 | 10.00M |
| 335 | INNV | InnovAge Holding Corp. | 1.27B | 1.19% | 256,300 | 949.17M |
| 336 | XERS | Xeris Biopharma Holdings, Inc. | 1.24B | 4.35% | 1,978,998 | 314.85M |
| 337 | ALVO | Alvotech | 1.24B | 1.37% | 787,900 | 562.04M |
| 338 | PAHC | Phibro Animal Health Corporation | 1.24B | -1.74% | 198,260 | 1.50B |
| 339 | ENOV | Enovis Corporation | 1.22B | -0.70% | 873,382 | 2.28B |
| 340 | MNKD | MannKind Corporation | 1.21B | 1.03% | 2,985,901 | 360.78M |
| 341 | AMN | AMN Healthcare Services, Inc. | 1.21B | 2.97% | 627,695 | 3.42B |
| 342 | BLFS | BioLife Solutions, Inc. | 1.21B | -0.44% | 750,616 | 101.66M |
| 343 | KMTS | Kestra Medical Technologies, Ltd. | 1.21B | -0.19% | 235,899 | 83.72M |
| 344 | EYPT | EyePoint, Inc. | 1.21B | 4.73% | 1,551,535 | 7.61M |
| 345 | INSP | Inspire Medical Systems, Inc. | 1.20B | 0.97% | 793,035 | 915.25M |
| 346 | PNTG | The Pennant Group, Inc. | 1.19B | 1.78% | 290,587 | 1.02B |
| 347 | IRMD | IRADIMED CORPORATION | 1.18B | 0.73% | 148,141 | 86.28M |
| 348 | PRCT | PROCEPT BioRobotics Corporation | 1.17B | -2.18% | 2,026,238 | 322.02M |
| 349 | AVNS | Avanos Medical, Inc. | 1.17B | 0.12% | 352,676 | 715.90M |
| 350 | AHG | Akso Health Group | 1.17B | 1.49% | 34,127 | 14.84M |
| 351 | WVE | Wave Life Sciences Ltd. | 1.16B | -2.11% | 2,366,079 | 71.80M |
| 352 | ABSI | Absci Corporation | 1.16B | -11.79% | 5,999,884 | 1.84M |
| 353 | SDGR | Schrödinger, Inc. | 1.12B | -1.25% | 1,213,030 | 254.91M |
| 354 | COLL | Collegium Pharmaceutical, Inc. | 1.12B | 3.50% | 317,955 | 796.33M |
| 355 | OPK | OPKO Health, Inc. | 1.10B | 2.10% | 2,843,246 | 581.12M |
| 356 | MGTX | MeiraGTx Holdings plc | 1.09B | 2.87% | 1,147,571 | 79.76M |
| 357 | CGEM | Cullinan Therapeutics, Inc. | 1.09B | 2.60% | 1,960,284 | - |
| 358 | OMDA | Omada Health, Inc. | 1.09B | 1.78% | 1,149,936 | 283.30M |
| 359 | CRVS | Corvus Pharmaceuticals, Inc. | 1.06B | 0.56% | 920,064 | - |
| 360 | PSNL | Personalis, Inc. | 1.05B | -1.08% | 1,881,688 | 64.52M |
| 361 | XNCR | Xencor, Inc. | 1.04B | 0.50% | 1,142,538 | 97.36M |
| 362 | AZTA | Azenta, Inc. | 1.02B | -0.31% | 486,827 | 596.48M |
| 363 | SPRY | ARS Pharmaceuticals, Inc. | 1.02B | 3.01% | 1,304,902 | 98.99M |
| 364 | CNMD | CONMED Corporation | 1.02B | 3.87% | 581,540 | 1.37B |
| 365 | SPTX | Seaport Therapeutics, Inc. | 1.02B | 5.45% | 322,379 | - |
| 366 | NUTX | Nutex Health Inc. | 1.01B | -1.96% | 98,955 | 879.95M |
| 367 | SANA | Sana Biotechnology, Inc. | 1.00B | -0.30% | 2,862,881 | - |
| 368 | AORT | Artivion, Inc. | 1.00B | 2.73% | 597,695 | 458.69M |
| 369 | CRON | Cronos Group Inc. | 1.00B | 1.51% | 743,920 | 159.54M |
| 370 | AVR | Anteris Technologies Global Corp. | 1.00B | 7.19% | 1,553,981 | 1.85M |
| 371 | BIOA | BioAge Labs, Inc. | 992.19M | 3.96% | 498,065 | 10.32M |
| 372 | TNDM | Tandem Diabetes Care, Inc. | 987.50M | 0.49% | 3,498,149 | 1.03B |
| 373 | DBVT | DBV Technologies S.A. | 968.08M | 2.61% | 376,501 | 5.74M |
| 374 | USPH | U.S. Physical Therapy, Inc. | 966.39M | 1.58% | 129,167 | 787.69M |
| 375 | LXRX | Lexicon Pharmaceuticals, Inc. | 959.46M | 0.47% | 2,774,240 | 69.64M |
| 376 | EVO | Evotec SE | 951.37M | - | 20,109 | 859.03M |
| 377 | REPL | Replimune Group, Inc. | 942.98M | 2.15% | 2,964,148 | - |
| 378 | AVTX | Avalo Therapeutics, Inc. | 937.24M | 4.39% | 1,969,536 | 59.00K |
| 379 | PHAR | Pharming Group N.V. | 931.75M | 1.26% | 7,275 | 369.49M |
| 380 | PCRX | Pacira BioSciences, Inc. | 925.07M | 3.52% | 408,146 | 734.86M |
| 381 | ORIC | ORIC Pharmaceuticals, Inc. | 922.34M | -0.22% | 1,181,180 | - |
| 382 | KURA | Kura Oncology, Inc. | 921.48M | 0.19% | 1,112,961 | 71.64M |
| 383 | OLMA | Olema Pharmaceuticals, Inc. | 919.77M | 5.30% | 2,368,326 | - |
| 384 | ETON | Eton Pharmaceuticals, Inc. | 917.37M | 2.35% | 572,015 | 86.93M |
| 385 | JANX | Janux Therapeutics, Inc. | 909.28M | 3.97% | 1,188,650 | 13.73M |
| 386 | LMRI | Lumexa Imaging Holdings, Inc. | 906.04M | -0.63% | 303,877 | 1.03B |
| 387 | GDRX | GoodRx Holdings, Inc. | 904.26M | 3.89% | 710,337 | 787.89M |
| 388 | ODTX | Odyssey Therapeutics, Inc. | 888.14M | -0.91% | 397,745 | 1.06M |
| 389 | DRTS | Alpha Tau Medical Ltd. | 883.73M | -2.29% | 612,554 | - |
| 390 | ABUS | Arbutus Biopharma Corporation | 879.04M | -1.55% | 3,493,864 | 191.45M |
| 391 | LBRX | LB Pharmaceuticals Inc | 877.51M | 2.44% | 824,513 | - |
| 392 | TBPH | Theravance Biopharma, Inc. | 874.85M | 2.48% | 676,267 | 109.78M |
| 393 | EVMN | Evommune, Inc. | 873.45M | 7.54% | 716,366 | 10.00M |
| 394 | TALK | Talkspace, Inc. | 871.07M | -0.19% | 4,276,946 | 238.37M |
| 395 | GERN | Geron Corporation | 866.05M | 0.75% | 13,103,262 | 196.12M |
| 396 | SLDB | Solid Biosciences Inc. | 865.37M | 5.90% | 3,143,314 | - |
| 397 | ANNX | Annexon, Inc. | 865.09M | 4.76% | 5,852,081 | - |
| 398 | PHAT | Phathom Pharmaceuticals, Inc. | 862.61M | 1.59% | 604,989 | 204.89M |
| 399 | AMPH | Amphastar Pharmaceuticals, Inc. | 861.13M | 6.55% | 660,872 | 720.53M |
| 400 | DSGN | Design Therapeutics, Inc. | 858.16M | 0.29% | 676,376 | - |
| 401 | ANRO | Alto Neuroscience, Inc. | 857.70M | 6.59% | 404,615 | - |
| 402 | INMD | InMode Ltd. | 845.84M | 1.06% | 521,567 | 374.64M |
| 403 | CERT | Certara, Inc. | 840.05M | 1.12% | 2,643,174 | 419.75M |
| 404 | QDEL | QuidelOrtho Corporation | 813.86M | -3.52% | 1,141,689 | 2.66B |
| 405 | ESPR | Esperion Therapeutics, Inc. | 813.48M | - | 5,646,803 | 418.24M |
| 406 | VOR | Vor Biopharma Inc. | 804.66M | -0.60% | 1,260,891 | - |
| 407 | BVS | Bioventus Inc. | 776.04M | 5.69% | 484,364 | 576.30M |
| 408 | AURA | Aura Biosciences, Inc. | 774.30M | 1.01% | 500,366 | - |
| 409 | ZVRA | Zevra Therapeutics, Inc. | 768.50M | 2.77% | 1,373,000 | 122.29M |
| 410 | OMER | Omeros Corporation | 758.49M | 1.45% | 1,073,153 | 9.89M |
| 411 | IVA | Inventiva S.A. | 750.68M | 5.70% | 1,527,439 | 7.94M |
| 412 | HSTM | HealthStream, Inc. | 749.66M | 1.18% | 140,533 | 311.78M |
| 413 | GMRS | GMR Solutions Inc. | 719.44M | -2.77% | 939,597 | 5.83B |
| 414 | ALLO | Allogene Therapeutics, Inc. | 714.47M | -1.43% | 4,811,703 | 22.00K |
| 415 | RLMD | Relmada Therapeutics, Inc. | 710.11M | -1.74% | 1,674,458 | - |
| 416 | OCS | Oculis Holding AG | 707.75M | 0.43% | 841,926 | 1.40M |
| 417 | SIBN | SI-BONE, Inc. | 707.37M | 0.82% | 386,491 | 206.22M |
| 418 | IMMX | Immix Biopharma, Inc. | 705.49M | 5.43% | 1,631,654 | - |
| 419 | CLYM | Climb Bio, Inc. | 704.30M | 0.99% | 1,195,217 | - |
| 420 | CBLL | CeriBell, Inc. | 697.77M | 1.16% | 273,676 | 95.07M |
| 421 | TENX | Tenax Therapeutics, Inc. | 696.89M | 11.35% | 1,018,498 | - |
| 422 | NNNN | Anbio Biotechnology | 689.09M | -4.68% | 28,140 | 8.65M |
| 423 | ACRS | Aclaris Therapeutics, Inc. | 687.15M | 1.65% | 1,865,406 | 8.37M |
| 424 | CTMX | CytomX Therapeutics, Inc. | 685.76M | 3.62% | 3,554,161 | 35.54M |
| 425 | SSII | SS Innovations International, Inc. | 680.45M | 1.19% | 36,322 | 48.47M |
| 426 | CRMD | CorMedix Inc. | 674.69M | -2.49% | 1,272,538 | 400.05M |
| 427 | CADL | Candel Therapeutics, Inc. | 665.29M | -0.77% | 1,378,088 | - |
| 428 | RIGL | Rigel Pharmaceuticals, Inc. | 658.86M | -0.34% | 257,500 | 299.77M |
| 429 | SGP | SpyGlass Pharma, Inc. | 657.50M | 1.71% | 74,119 | - |
| 430 | DRUG | Bright Minds Biosciences Inc. | 655.78M | 2.58% | 235,167 | - |
| 431 | CSTL | Castle Biosciences, Inc. | 648.45M | 0.85% | 439,263 | 339.92M |
| 432 | SLBT | SL Science Holding Limited | 640.04M | -12.39% | 231,801 | - |
| 433 | IRWD | Ironwood Pharmaceuticals, Inc. | 635.41M | 1.05% | 1,444,966 | 361.51M |
| 434 | AQST | Aquestive Therapeutics, Inc. | 631.01M | 6.57% | 2,988,647 | 50.27M |
| 435 | TRAX | First Tracks Biotherapeutics, Inc. | 620.39M | -2.95% | 544,432 | - |
| 436 | FTH | Faeth Therapeutics, Inc. | 618.69M | 3.49% | 140,305 | - |
| 437 | BBNX | Beta Bionics, Inc. | 609.16M | -0.22% | 864,206 | 110.24M |
| 438 | FDMT | 4D Molecular Therapeutics, Inc. | 606.40M | 11.32% | 2,068,962 | 88.24M |
| 439 | BBOT | BridgeBio Oncology Therapeutics, Inc. | 600.80M | -4.70% | 805,702 | - |
| 440 | TCMD | Tactile Systems Technology, Inc. | 596.61M | 0.88% | 185,375 | 343.52M |
| 441 | AGMB | AgomAb Therapeutics NV | 588.02M | 0.84% | 54,271 | - |
| 442 | PRME | Prime Medicine, Inc. | 585.20M | -3.86% | 2,965,537 | 4.03M |
| 443 | BWAY | BrainsWay Ltd. | 582.36M | 0.07% | 70,612 | 56.22M |
| 444 | CBIO | Crescent Biopharma, Inc. | 581.51M | -0.40% | 227,200 | 11.88M |
| 445 | DNA | Ginkgo Bioworks Holdings, Inc. | 578.77M | -1.99% | 969,505 | 151.40M |
| 446 | TECX | Tectonic Therapeutic, Inc. | 577.21M | 0.82% | 86,276 | - |
| 447 | ALT | Altimmune, Inc. | 565.92M | -0.68% | 4,223,911 | 36.00K |
| 448 | PHR | Phreesia, Inc. | 565.58M | 2.58% | 812,492 | 495.59M |
| 449 | GYRE | Gyre Therapeutics, Inc. | 560.11M | - | 53,330 | 117.05M |
| 450 | CLPT | ClearPoint Neuro, Inc. | 555.71M | 8.62% | 1,397,304 | 40.61M |
| 451 | MDXG | MiMedx Group, Inc. | 555.57M | 1.63% | 833,293 | 389.42M |
| 452 | TLRY | Tilray Brands, Inc. | 549.89M | 0.44% | 2,626,310 | 858.28M |
| 453 | MNPR | Monopar Therapeutics Inc. | 547.76M | 19.09% | 278,172 | - |
| 454 | PROK | ProKidney Corp. | 543.71M | -1.10% | 803,320 | 889.00K |
| 455 | NPCE | NeuroPace, Inc. | 542.77M | 3.58% | 250,887 | 99.53M |
| 456 | EVH | Evolent Health, Inc. | 539.91M | 7.14% | 1,987,702 | 1.89B |
| 457 | ASMB | Assembly Biosciences, Inc. | 531.10M | 6.56% | 253,783 | 71.10M |
| 458 | XOMA | XOMA Royalty Corporation | 526.10M | -0.12% | 134,937 | 48.56M |
| 459 | CTKB | Cytek Biosciences, Inc. | 525.61M | 5.44% | 1,453,308 | 204.17M |
| 460 | ARVN | Arvinas, Inc. | 525.20M | 5.17% | 852,166 | 89.40M |
| 461 | CERS | Cerus Corporation | 518.96M | -0.38% | 2,687,593 | 216.56M |
| 462 | FLGT | Fulgent Genetics, Inc. | 516.32M | 1.91% | 255,648 | 320.35M |
| 463 | ANGO | AngioDynamics, Inc. | 515.61M | -0.16% | 286,194 | 313.73M |
| 464 | EIKN | Eikon Therapeutics, Inc. | 514.86M | -1.14% | 223,298 | - |
| 465 | RGNX | REGENXBIO Inc. | 514.39M | 9.70% | 2,968,624 | 87.82M |
| 466 | ACHV | Achieve Life Sciences, Inc. | 514.32M | -1.76% | 2,124,551 | - |
| 467 | KYTX | Kyverna Therapeutics, Inc. | 512.50M | 1.57% | 519,736 | - |
| 468 | CTEV | Claritev Corporation | 512.46M | 5.70% | 136,460 | 978.76M |
| 469 | RZLT | Rezolute, Inc. | 510.84M | -5.05% | 1,652,566 | - |
| 470 | MCTA | Charming Medical Limited | 504.26M | -0.85% | - | 5.42M |
| 471 | TOI | The Oncology Institute, Inc. | 502.91M | 0.40% | 1,155,424 | 545.76M |
| 472 | PRTA | Prothena Corporation plc | 499.97M | 4.37% | 458,045 | 57.94M |
| 473 | VALN | Valneva SE | 498.24M | 0.93% | 16,569 | 180.25M |
| 474 | CABA | Cabaletta Bio, Inc. | 492.43M | 0.33% | 3,138,371 | - |
| 475 | NGNE | Neurogene Inc. | 487.65M | -4.31% | 118,370 | 925.00K |
| 476 | STRO | Sutro Biopharma, Inc. | 483.69M | -7.48% | 226,910 | 99.61M |
| 477 | SRTA | Strata Critical Medical, Inc. | 481.95M | -3.13% | 1,166,654 | 228.58M |
| 478 | ARTV | Artiva Biotherapeutics, Inc. | 476.16M | 4.70% | 479,567 | 251.00K |
| 479 | KIDS | OrthoPediatrics Corp. | 471.96M | 1.18% | 130,394 | 243.30M |
| 480 | OCGN | Ocugen, Inc. | 467.16M | 6.98% | 8,224,977 | 4.47M |
| 481 | CCCC | C4 Therapeutics, Inc. | 466.59M | 2.43% | 2,912,409 | 34.86M |
| 482 | NVCT | Nuvectis Pharma, Inc. | 465.52M | 6.17% | 281,282 | - |
| 483 | MOBI | Mobia Medical, Inc. | 456.51M | -1.01% | 114,857 | 38.45M |
| 484 | NRC | NRC Health | 451.64M | 2.82% | 93,194 | 138.64M |
| 485 | CTNM | Contineum Therapeutics, Inc. | 445.27M | 2.50% | 293,627 | - |
| 486 | EOLS | Evolus, Inc. | 443.86M | 2.28% | 547,591 | 301.79M |
| 487 | FBRX | Forte Biosciences, Inc. | 443.51M | -0.71% | 348,196 | - |
| 488 | VREX | Varex Imaging Corporation | 443.38M | 1.15% | 400,715 | 857.50M |
| 489 | BNTC | Benitec Biopharma Inc. | 442.48M | 4.72% | 97,837 | - |
| 490 | AUTL | Autolus Therapeutics plc | 441.80M | 11.41% | 1,572,640 | 92.62M |
| 491 | VTVT | vTv Therapeutics Inc. | 438.37M | 4.14% | 41,793 | 36.84M |
| 492 | MYGN | Myriad Genetics, Inc. | 437.30M | 2.89% | 1,271,865 | 829.00M |
| 493 | SGMT | Sagimet Biosciences Inc. | 435.97M | -0.56% | 751,505 | - |
| 494 | IPSC | Century Therapeutics, Inc. | 434.66M | 4.78% | 1,259,848 | 109.16M |
| 495 | PRLD | Prelude Therapeutics Incorporated | 434.40M | 1.39% | 454,277 | 16.72M |
| 496 | OVID | Ovid Therapeutics Inc. | 433.01M | 3.11% | 2,421,899 | 7.12M |
| 497 | WEAV | Weave Communications, Inc. | 432.84M | 5.43% | 990,338 | 248.72M |
| 498 | SOPH | SOPHiA GENETICS SA | 430.51M | -2.06% | 111,131 | 81.18M |
| 499 | DCTH | Delcath Systems, Inc. | 424.27M | 6.78% | 613,220 | 90.44M |
| 500 | ANL | Adlai Nortye Ltd. | 424.00M | 1.92% | 103,679 | 5.00M |